KinMet 2004
Satellite Symposium on
Kinetics and Kinetic Modeling of Lipoprotein, Lipid, and Sterol Metabolism in
Systems Ranging from Human Subjects to Cultured Cells
Wednesday, May 5, 2004
12 noon - 6 PM
San
Francisco Hilton (Union Square) Rooms 15 and 16.
You are cordially invited to attend our 34th annual meeting. Registration is free and this is among the very few meetings each year at which experimental biomedicine and kinetic modeling are truly integrated. Again this year we are planning three sessions, a format that has worked beautifully for the last several years. To offer a talk for one of the three sessions, simply click on the name of the session chair in the program listing below and send us an e-mail.
There will be coffee and soft drinks continuously available for attendees at this meeting.
Note to speakers: Both a slide projector and a computer (LCD) projector will be available. We will also have an overhead projector.
| Session 1: 12noon to 2:00 PM | Session 2: 2:00 PM to 4:00PM | Session 3: 4:00 PM to 6:00 PM |
| Modeling
Methodologies in Lipoprotein Metabolism Chair: Hugh Barrett |
ApoB-Containing
Lipoprotein Metabolism and Modeling Chair: Frank Sacks |
High
Density Lipoprotein Metabolism and Modeling Chair: Ernie Schaefer |
| 12:00 | 2:00 Berman-Zech Award Lecture Modeling of Human Apolipoprotein A-I and B Metabolism, Hugh Barrett, University of Western Australia | 4:00 Robert I Levy Award Lecture Advances in HDL Metabolism, H. Bryan Brewer, National Institutes of Health |
| 12:30 A theoretical consideration in an integrated pool model for VLDL apoB and TG kinetics and delipidation, Sekhar Ramakrishnan, Columbia University | 2:30 ApoB
Kinetics in hepatic lipase deficient patients treated with fibrates,
Benoît Lamarche, Laval University |
4:30 Role of CETP in HDL metabolism and Atherosclerosis, Ernie Schaefer, Tufts Univ. |
| 1:00 HDL metabolism: a model of LpAI:AII kinetics, Hugh Barrett, University of Western Australia | 2:45 Lipoprotein lipase bound to apoB lipoproteins in humans: role in clearance of postprandial lipoproteins, Chunyu Zheng, Harvard School of Public Health | 4:45 |
| 5:00 | ||
| 3:15 Kinetics of apoB100 metabolism in miniature pigs following treatment with an inhibitior of 2,3- oxidosqualene cyclase: A novel cholesterol lowering agent, Murray Huff, University of Western Ontario | 5:15 | |
| 3:45 | 5:40 |